JIP
MRK icon

Jaffetilchin Investment Partners’s Merck MRK Stock Holding History

Jaffetilchin Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Sell
19,206
-683
-3% -$78.9K 0.14% 116
2025
Q4 		$2.09M Buy
19,889
+169
+0.9% +$15.9K 0.12% 117
2025
Q3 		$1.66M Sell
19,720
-742
-4% -$61.1K 0.1% 137
2025
Q2 		$1.62M Sell
20,462
-10,298
-33% -$819K 0.11% 128
2025
Q1 		$2.76M Buy
30,760
+1,370
+5% +$128K 0.2% 89
2024
Q4 		$2.92M Buy
29,390
+2,059
+8% +$212K 0.21% 78
2024
Q3 		$3.1M Buy
27,331
+766
+3% +$91K 0.23% 70
2024
Q2 		$3.29M Buy
26,565
+545
+2% +$70.2K 0.28% 60
2024
Q1 		$3.43M Buy
26,020
+575
+2% +$70.9K 0.31% 57
2023
Q4 		$2.77M Buy
25,445
+1,580
+7% +$164K 0.27% 65
2023
Q3 		$2.46M Sell
23,865
-2,915
-11% -$314K 0.27% 64
2023
Q2 		$3.09M Sell
26,780
-394
-1% -$44.7K 0.33% 55
2023
Q1 		$2.89M Sell
27,174
-657
-2% -$70.9K 0.33% 59
2022
Q4 		$3.09M Sell
27,831
-482
-2% -$49.3K 0.38% 60
2022
Q3 		$2.44M Buy
28,313
+758
+3% +$67.7K 0.31% 52
2022
Q2 		$2.51M Buy
27,555
+221
+0.8% +$19.6K 0.3% 60
2022
Q1 		$2.48M Buy
27,334
+5,803
+27% +$458K 0.29% 56
2021
Q4 		$1.65M Buy
21,531
+1,208
+6% +$96.2K 0.16% 96
2021
Q3 		$1.53M Sell
20,323
-11,708
-37% -$890K 0.16% 95
2021
Q2 		$2.55M Buy
32,031
+10,654
+50% +$792K 0.18% 94
2021
Q1 		$1.57M Buy
21,377
+6,626
+45% +$489K 0.19% 101
2020
Q4 		$1.15M Buy
14,751
+191
+1% +$14.6K 0.16% 97
2020
Q3 		$1.15M Buy
14,560
+1,640
+13% +$128K 0.21% 65
2020
Q2 		$953K Buy
12,920
+1,658
+15% +$125K 0.21% 65
2020
Q1 		$827K Sell
11,262
-637
-5% -$50.1K 0.29% 50
2019
Q4 		$1.03M Buy
11,899
+920
+8% +$75.6K 0.22% 70
2019
Q3 		$882K Buy
10,979
+560
+5% +$44.9K 0.21% 70
2019
Q2 		$834K Buy
+10,419
New +$798K 0.19% 82

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jaffetilchin Investment Partners's MRK Position: Q1 2026 in Review

Jaffetilchin Investment Partners reduced its Merck (MRK) stake by 3.4% in Q1 2026, selling an estimated $78.9K and leaving 19,206 shares worth $2.31M. The position accounts for 0.14% of the portfolio, ranked #116.

Jaffetilchin Investment Partners first reported a position in MRK in Q2 2019 and has held it in 28 quarters since. The position peaked at $3.43M in Q1 2024. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jaffetilchin Investment Partners held 19,206 shares of Merck worth $2.31M as of Q1 2026.
  • Jaffetilchin Investment Partners sold 683 Merck shares in Q1 2026, an estimated $78.9K.
  • Merck made up 0.14% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #116 holding.
  • Jaffetilchin Investment Partners first reported a position in Merck in Q2 2019 and has held it in 28 quarters since.
  • Jaffetilchin Investment Partners's Merck position peaked at $3.43M in Q1 2024.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.